The Morbidity and Mortality of End Stage Renal Disease in Sickle Cell Disease

Overview

Journal Am J Hematol

Specialty Hematology

Date 2019 Feb 19

PMID 30773675

Citations 9

Authors

Maya Viner

Jifang Zhou

David Allison

Jin Han

Robert E Molokie

Shivi Jain

Michel Gowhari

Victor R Gordeuk

Gregory Calip

Santosh L Saraf

Affiliations

Soon will be listed here.

Citing Articles

Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study.

Valle J, Lebensburger J, Garimella P, Gopal S JMIR Public Health Surveill. 2024; 10:e57290.

PMID: 39008353 PMC: 11287091. DOI: 10.2196/57290.

Sickle Cell Disease and CKD: An Update.

Zahr R, Saraf S Am J Nephrol. 2023; 55(1):56-71.

PMID: 37899028 PMC: 10872505. DOI: 10.1159/000534865.

Kidney Transplantation in a Patient Affected by Sickle Cell Trait: A Case Report and State-of-the-Art Review.

Picciotto D, Bussalino E, Viazzi F, Paoletti E, Esposito P Cureus. 2023; 15(1):e33400.

PMID: 36751159 PMC: 9899094. DOI: 10.7759/cureus.33400.

Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - A 19-year United States Renal Data System study.

Winer J, Yee M, Ataga K, Lebensburger J, Zahr R Br J Haematol. 2022; 199(5):e43-e47.

PMID: 36191963 PMC: 10739628. DOI: 10.1111/bjh.18494.

Homozygous sickle cell disease related mortality in Senegal (2011-2020).

Seck M, Ba O, Faye B, Toure S, Gueye Y, Dieng N EJHaem. 2022; 2(4):711-715.

PMID: 35845188 PMC: 9176000. DOI: 10.1002/jha2.273.

References

McClellan A, Luthi J, Lynch J, Soucie J, Kulkarni R, Guasch A . High one year mortality in adults with sickle cell disease and end-stage renal disease. Br J Haematol. 2012; 159(3):360-7. PMC: 4562224. DOI: 10.1111/bjh.12024. View

Collins A, Foley R, Gilbertson D, Chen S . The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009; 4 Suppl 1:S5-11. DOI: 10.2215/CJN.05980809. View

Platt O, Brambilla D, Rosse W, Milner P, Castro O, Steinberg M . Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994; 330(23):1639-44. DOI: 10.1056/NEJM199406093302303. View

Nielsen L, Canoui-Poitrine F, Jais J, Dahmane D, Bartolucci P, Bentaarit B . Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients. Br J Haematol. 2016; 174(1):148-52. DOI: 10.1111/bjh.14040. View

Delmez J, Slatopolsky E . Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis. 1992; 19(4):303-17. DOI: 10.1016/s0272-6386(12)80446-x. View